NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis $21.71 +0.06 (+0.28%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$21.62▼$22.0950-Day Range$20.62▼$26.1752-Week Range$20.41▼$47.25Volume87,959 shsAverage Volume90,157 shsMarket Capitalization$518.37 millionP/E Ratio17.51Dividend Yield2.21%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get National Research alerts: Email Address Ad Porter & CompanyWhy billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. Click here for my exclusive video About National Research Stock (NASDAQ:NRC)National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.Read More NRC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NRC Stock News HeadlinesSeptember 7 at 6:36 AM | msn.com3D Imaging Could Transform Plastic RecyclingAugust 28, 2024 | finanznachrichten.deStock Trend Capital Inc.: Stock Trend Capital Provides Government Grant Update on Younet AI InvestmentSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 27, 2024 | finanznachrichten.deStock Trend Capital Inc.: Stock Trend Capital Provides Government Grant Update on Younet InvestmentAugust 27, 2024 | finance.yahoo.comStock Trend Capital Provides Government Grant Update on Younet InvestmentAugust 27, 2024 | theglobeandmail.comLexaria (NASDAQ: LEXX) Validates Tech’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment MarketAugust 23, 2024 | finance.yahoo.comNRC Health unveils AI-enabled healthcare solutionsAugust 21, 2024 | uk.finance.yahoo.comKane Biotech Inc. (KNE.V)September 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 15, 2024 | msn.comThoroughbred Fundamentals: Hard Keepers Don’t Need To Be ThinAugust 15, 2024 | msn.comSenate votes nearly unanimously to pass revolutionary piece of nuclear energy legislation — here's what it would doAugust 14, 2024 | stockhouse.comKane Biotech Receives Funding Support to Expand the revyve(TM) Antimicrobial Wound Gel FamilyAugust 13, 2024 | finance.yahoo.comKane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel FamilyAugust 6, 2024 | businesswire.comNational Research Corporation Announces Second Quarter ResultsAugust 1, 2024 | reuters.comNRC Chair hails culture change at nuclear regulatorJuly 30, 2024 | finance.yahoo.comNational Research Corporation (NASDAQ:NRC) is a favorite amongst institutional investors who own 52%July 27, 2024 | msn.comBoost for science: $1.5 billion in federal funding for two new Ottawa labsJuly 26, 2024 | finance.yahoo.comGovernment of Canada announces milestones for new science facilities in National Capital AreaSee More Headlines Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 7/15 Dividend6/28/2024Dividend Payable7/15/2024Last Earnings8/06/2024Today9/07/2024Ex-Dividend for 10/11 Dividend9/27/2024Dividend Payable10/11/2024Next Earnings (Confirmed)11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:NRC CUSIPN/A CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees435Year Founded1981Profitability EPS (Most Recent Fiscal Year)$1.24 Trailing P/E Ratio17.51 Forward P/E RatioN/A P/E GrowthN/ANet Income$30.97 million Net Margins20.01% Pretax Margin26.00% Return on Equity63.64% Return on Assets24.26% Debt Debt-to-Equity Ratio0.64 Current Ratio0.37 Quick Ratio0.37 Sales & Book Value Annual Sales$146.28 million Price / Sales3.54 Cash Flow$1.45 per share Price / Cash Flow14.98 Book Value$1.68 per share Price / Book12.92Miscellaneous Outstanding Shares23,877,000Free Float23,399,000Market Cap$518.37 million OptionableOptionable Beta0.48 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Michael D. Hays (Age 69)Founder, CEO, President & Director Comp: $131.11kMs. Helen L. Hrdy (Age 59)Chief Customer Officer Comp: $291.51kMr. Christophe Louvion (Age 51)Chief Product & Technology Officer Mr. Andy Monnich (Age 48)Chief Corporate Development Officer Mr. Jon BoumsteinChief Delivery OfficerDr. Gregory Makoul M.S.Ph.D., Chief Transformation OfficerMr. Jason Hahn (Age 52)Chief Revenue Officer Ms. Linda StacySecretaryMegan CharkoSenior Manager of Content MarketingMore ExecutivesKey CompetitorsOmniAbNASDAQ:OABIAbsciNASDAQ:ABSIMaxCyteNASDAQ:MXCTPrecigenNASDAQ:PGENLuna InnovationsNASDAQ:LUNAView All CompetitorsInsiders & InstitutionsAlgert Global LLCBought 3,700 shares on 8/16/2024Ownership: 0.179%Creative PlanningBought 7,067 shares on 8/16/2024Ownership: 0.051%Quarry LPBought 2,353 shares on 8/16/2024Ownership: 0.010%Select Equity Group L.P.Bought 2,408 shares on 8/15/2024Ownership: 0.149%AQR Capital Management LLCBought 4,601 shares on 8/15/2024Ownership: 0.121%View All Insider TransactionsView All Institutional Transactions NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed this year? National Research's stock was trading at $39.56 on January 1st, 2024. Since then, NRC stock has decreased by 45.1% and is now trading at $21.71. View the best growth stocks for 2024 here. How were National Research's earnings last quarter? National Research Co. (NASDAQ:NRC) released its earnings results on Tuesday, August, 6th. The company reported $0.26 earnings per share for the quarter. The firm had revenue of $35.02 million for the quarter. National Research had a net margin of 20.01% and a trailing twelve-month return on equity of 63.64%. What is Michael D. Hays' approval rating as National Research's CEO? 85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees. Does National Research have any subsidiaries? The following companies are subsidiaries of National Research: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada. Who are National Research's major shareholders? Top institutional investors of National Research include Kayne Anderson Rudnick Investment Management LLC (12.75%), Dimensional Fund Advisors LP (2.57%), Renaissance Technologies LLC (1.81%) and QV Investors Inc. (1.42%). Insiders that own company stock include Amandla Mk Trust, Kevin R Karas and Jona S Raasch. View institutional ownership trends. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE) and Toronto-Dominion Bank (TD). This page (NASDAQ:NRC) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRC Stock Alerts